FDA Inspection 946028 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3003733819

The FDA completed an inspection of Biomat USA, Inc. on September 29, 2015 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 29, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Indianapolis, IN (United States)